Streetbeat News

Stock Prices

ALNY

Alnylam Pharmaceuticals announced positive topline results from its HELIOS-B Phase 3 study of Vutrisiran. The study achieved statistical significance on both primary and all secondary endpoints.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 11:02 am

EFTR

eFFECTOR Therapeutics has announced plans to wind down its operations and seek potential strategic alternatives. The company also expects to delist from Nasdaq.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 11:01 am

ALNY

Trading in ALNY was halted at 6:55:00 a.m. ET pending news. Investors should stay tuned for updates as the halt indicates significant news is forthcoming.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 10:55 am

BA

ITA

PPA

Boeing Co (NYSE:BA) risks potential criminal charges as U.S. prosecutors reportedly recommend legal action against the company for allegedly breaching a 2021 deferred prosecution agreement following two fatal 737 MAX crashes. The Justice Department has until July 7 to decide on prosecuting Boeing, which could result in significant penalties. Boeing has denied any wrongdoing, but discussions with the Justice Department are ongoing. The stock has lost more than 14% in the last 12 months. Investors can gain exposure to Boeing via IShares U.S. Aerospace & Defense ETF (BATS:ITA) and Invesco Aerospace & Defense ETF (NYSE:PPA).

Portfolio Pulse from Shivani Kumaresan

June 24, 2024 | 10:47 am

TSLA

Elon Musk has called for legal reform on class action lawsuits, arguing that they often do not represent shareholders and primarily benefit law firms. This comes in light of a lawsuit that led to the revocation of his 2018 pay package, which was recently re-approved by Tesla shareholders.

Portfolio Pulse from Anan Ashraf

June 24, 2024 | 10:44 am

NXE

NexGen Energy's Rook I Project is advancing as the Canadian Nuclear Safety Commission (CNSC) reviews the final Environmental Impact Statement (EIS). The CNSC has started a 60-day technical review, after which a Federal Commission Hearing date will be set. NexGen is ready to commence major construction upon receiving the remaining approvals.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 10:37 am

ADRT

GIGA

Gresham Worldwide, Inc. (OTCQB:GIGA) and Ault Disruptive Technologies Corporation (NYSE:ADRT) have announced a merger agreement. The transaction, valued at approximately $83 million, will see Gresham redomicile to Delaware and rebrand as Gresham Worldwide, Inc., listed on the NYSE American under the ticker symbol 'GWWI'. The merger aims to expand Gresham's defense and healthcare technology capabilities.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 10:35 am

GTHX

G1 Therapeutics' Phase 3 trial of Trilaciclib in metastatic triple-negative breast cancer did not achieve statistical significance in overall survival. The company will now focus on the extensive-stage small cell lung cancer market and is sufficiently funded to achieve anticipated profitability by the second half of 2025.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 10:34 am

UA

Under Armour (NYSE:UA) has agreed to settle a securities class action lawsuit for $434 million, covering claims from shareholders between 2015 and 2019. The company will use cash on hand or its credit facility to pay the settlement, which will be reflected in its fiscal 2025 financials. Under Armour denies any wrongdoing but aims to avoid litigation costs and distractions.

Portfolio Pulse from Lekha Gupta

June 24, 2024 | 10:26 am

AAPL

AMZN

GOOG

GOOGL

MSFT

Apple Inc. (NASDAQ:AAPL) is facing an EU antitrust probe for allegedly violating the Digital Markets Act, which could result in a fine of up to 10% of its global revenue. The investigation is part of broader regulatory scrutiny on major U.S. tech companies in Europe.

Portfolio Pulse from Benzinga Neuro

June 24, 2024 | 10:20 am